GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Quick Ratio

KPC Pharmaceuticals (SHSE:600422) Quick Ratio : 1.49 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. KPC Pharmaceuticals's quick ratio for the quarter that ended in Mar. 2025 was 1.49.

KPC Pharmaceuticals has a quick ratio of 1.49. It generally indicates good short-term financial strength.

The historical rank and industry rank for KPC Pharmaceuticals's Quick Ratio or its related term are showing as below:

SHSE:600422' s Quick Ratio Range Over the Past 10 Years
Min: 1.09   Med: 1.33   Max: 2.11
Current: 1.49

During the past 13 years, KPC Pharmaceuticals's highest Quick Ratio was 2.11. The lowest was 1.09. And the median was 1.33.

SHSE:600422's Quick Ratio is ranked worse than
53.84% of 1016 companies
in the Drug Manufacturers industry
Industry Median: 1.41 vs SHSE:600422: 1.49

KPC Pharmaceuticals Quick Ratio Historical Data

The historical data trend for KPC Pharmaceuticals's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Quick Ratio Chart

KPC Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 1.23 1.31 1.65 1.28

KPC Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 1.44 1.51 1.28 1.49

Competitive Comparison of KPC Pharmaceuticals's Quick Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's Quick Ratio distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's Quick Ratio falls into.


;
;

KPC Pharmaceuticals Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

KPC Pharmaceuticals's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Quick Ratio (A: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(8555-1539.79)/5490.859
=1.28

KPC Pharmaceuticals's Quick Ratio for the quarter that ended in Mar. 2025 is calculated as

Quick Ratio (Q: Mar. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(8680.727-1611.88)/4751.158
=1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KPC Pharmaceuticals  (SHSE:600422) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


KPC Pharmaceuticals Quick Ratio Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


KPC Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals Headlines

No Headlines